This post is sponsored by Xavier University.
The U.S. Food and Drug Administration (FDA) and Xavier University are leading the MedCon global medical device conference May 1-4 at Xavier University in Cincinnati.
Don’t miss this opportunity to engage with your colleagues from around the world. Last year, over 300 attendees traveled from nine countries and 23 states, representing 134 companies. World-renowned speakers address the most pressing issues faced by our industry and engage you in deep discussion.
Leading FDA officials, industry CEOs, congressional representatives and global industry experts attending include:
- Dr. Jeffrey Shuren: FDA Director, Center for Devices and Radiological Health
- Kem Hawkins: President, Cook Group Inc.
- Keith Flanagan: U.S. Senate Health, Education, Labor and Pension Committee
- Jack Kraeutler: CEO, Meridian Bioscience
- Steve Silverman: FDA Director, Office of Compliance
- Kim Trautman (invited): FDA Associate Director, International Affairs
- Monica Wilkins: Divisional Vice President, Abbott
- Gina Brackett: FDA, Compliance Officer, Cincinnati District
- Phil Phillips: President, Phillips Consulting LLC
- Mark Duval: President, Duval and Associates
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Benefits of Conference Attendance
For 2.5 days, MedCon (www.XavierMedCon.com) addresses topics such as how to implement the proposed 510(k) changes, implement effective CAPA systems, establish global regulatory strategy, and balance innovation with regulation and cost. The conference provides plenty of opportunity for you to engage the foremost thought leaders on issues that matter to you.
